SPHRY Financials 07/16/2014 16:38:23
Starpharma Holdings Ltd.
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue 2,223 2,813 2,275 1,776
Cost of Revenue - - - -
Gross Profit 2,223 2,813 2,275 1,776
Operating Expenses
Research and Development 3,208 12,391 6,409 4,834
Sales, General and Admin. 3,793 4,414 5,410 2,332
Non-Recurring Items - - - -
Other - - - -
Operating Income (4,778) (13,992) (9,543) (5,390)
Income From Continuing Operations
Add'l Income/Expense Items - - - -
Earnings Before Interest and Tax (4,778) (13,992) (9,544) (5,390)
Interest Expense 8 8 17 -
Earnings Before Tax (4,786) (14,000) (9,561) (5,390)
Income Tax - - - (3)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (4,786) (14,000) (9,561) (5,387)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (4,786) (14,000) (9,561) (5,387)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (4,786) (14,000) (9,561) (5,387)